Coming in 2025

Partner with the Leaders Building Medtech

June 10th - 13th, 2025 | The Ritz-Carlton, Millenia Singapore
Secure Your Spot arrow Registration is Officially Open

Trusted By The Companies Pioneering What’s Next

What is LSI Asia ‘25?

World-class executives, convening in world-class venues to do real business

With the global community built through LSI USA and LSI Europe and our partnerships in Singapore, China, Korea, Japan and more, LSI Asia will convene industry-leading startups, venture capital and private equity investors, strategics, and more.

Like LSI USA and LSI Europe, LSI Asia will not be held in a chaotic convention center. We have identified a world-class venue for our inaugural event where senior executives can do real business.

Speakers and Attendees
Industry-leading executives from emerging companies,
venture capital and private equity firms, family offices,
investment banks, global strategics, and more.
View all Attendees
Vy Tran

President, Asia Pacific and Japan

Siemens Healthineers

Dan Lippis

Corporate Vice President, JAPAC Region

Edwards Lifesciences

Joaquin Lasso

SVP & General Manager, Sports Medicine

Smith+Nephew

William Dai

Founding Managing Partner

ShangBay Capital

Joseph Mocanu

Managing Partner

Verge HealthTech Fund

Peter Horan

Managing Director, Asia-Pacific

BIOTRONIK

Harjit Gill

Chief Executive Officer

Asia Pacific Medical Technology Association

Jinghua (Michael) Wang

Managing Director, Greater China Ventures

Medtronic

Chris Eso

Vice President, Global Head of Corporate and 
Business Development, M&A and Ventures

Medtronic

Alok Mishra

Medtech Executive, Adjunct Associate Professor

Value Addition, and Duke-NUS Medical School

John Eng

Vice President Healthcare

Singapore Economic Development Board (EDB)

Collin Morrison

Senior Director, Venture Capital

Boston Scientific

Present at LSI Asia ‘25
Presenting Companies
Present to a full house of investors and strategics alongside
the CEOs and Founders building technology that is shaping
the future of healthcare.
  • Scout Health

    Presenter

    arrow
    Alex Jiao

    CEO

    Scout Health is bringing rapid molecular testing to the point-of-care. The Scout System packages similar technology to PCR lab-grade tests that normally require a clinic to be performed into a small hub and single-use tests. The system is currently approved for the testing of COVID, with additional tests for common illnesses in development.  Visit website.

    Scout Health

    Presenter

    arrow
    Alex Jiao

    CEO

    Scout Health is bringing rapid molecular testing to the point-of-care. The Scout System packages similar technology to PCR lab-grade tests that normally require a clinic to be performed into a small hub and single-use tests. The system is currently approved for the testing of COVID, with additional tests for common illnesses in development.  Visit website.

    Bionic Vision Technologies

    Presenter

    arrow
    Ash Attia

    CEO

    BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

    Bionic Vision Technologies

    Presenter

    arrow
    Ash Attia

    CEO

    BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

    Solenic Medical

    Presenter

    arrow
    James Lancaster

    CEO

    Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

    Solenic Medical

    Presenter

    arrow
    James Lancaster

    CEO

    Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

    Biorithm

    Presenter

    arrow
    Amrish Nair

    Founder/Director

    Femom is a comprehensive maternity care platform to improve perinatal outcomes through mobile technology and data science. Designed for in-home and hospital use, Femom's priority solution enables healthcare professionals to gain new insights to the health of the mother and fetus while offering more convenience and information. Visit website.

    Biorithm

    Presenter

    arrow
    Amrish Nair

    Founder/Director

    Femom is a comprehensive maternity care platform to improve perinatal outcomes through mobile technology and data science. Designed for in-home and hospital use, Femom's priority solution enables healthcare professionals to gain new insights to the health of the mother and fetus while offering more convenience and information. Visit website.

    Aqua Medical

    Presenter

    arrow
    Lloyd Mencinger

    President & CEO

    Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy. Visit website.

    Aqua Medical

    Presenter

    arrow
    Lloyd Mencinger

    President & CEO

    Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy. Visit website.

    Atmo Biosciences

    Presenter

    arrow
    Malcolm Hebblewhite

    President

    The Atmo Gas Capsule is a unique ingestible capsule to provides unique insights into gut health and microbiome function. The device assesses the functional health of the GI system by means of measuring gaseous biomarkers as it passes through the GI system. Atmo Biosciences investigational device offers the potential to shed new light on disorders of the gut, beginning with highly prevalent motility disorders such as gastroparesis and slow transit constipation. Visit website.

    Atmo Biosciences

    Presenter

    arrow
    Malcolm Hebblewhite

    President

    The Atmo Gas Capsule is a unique ingestible capsule to provides unique insights into gut health and microbiome function. The device assesses the functional health of the GI system by means of measuring gaseous biomarkers as it passes through the GI system. Atmo Biosciences investigational device offers the potential to shed new light on disorders of the gut, beginning with highly prevalent motility disorders such as gastroparesis and slow transit constipation. Visit website.

    Wellumio

    Presenter

    arrow
    Dr Shieak Tzeng

    Co-founder & CEO

    Wellumio is a venture-backed company specializing in portable MRI solutions for acute neuroimaging applications. The company’s core enabling technology is a novel pulse-gradient free nuclear magnetic resonance sensor platform with an initial focus on acute stroke triage and diagnosis. Visit website.

    Wellumio

    Presenter

    arrow
    Dr Shieak Tzeng

    Co-founder & CEO

    Wellumio is a venture-backed company specializing in portable MRI solutions for acute neuroimaging applications. The company’s core enabling technology is a novel pulse-gradient free nuclear magnetic resonance sensor platform with an initial focus on acute stroke triage and diagnosis. Visit website.

    BrainSpace

    Presenter

    arrow
    Caitlin Morse

    CEO

    BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

    BrainSpace

    Presenter

    arrow
    Caitlin Morse

    CEO

    BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

    Heteron Biotechnologies

    Presenter

    arrow
    Anastasia Rigas

    CEO

    Heteron's solution is a hand-held breath analyzer will screen and monitor for biomarkers of gastrointestinal and liver diseases. The technology is intended to replace existing diagnostic testing tools for point-of-care testing, ultimately allowing users to screen themselves and to monitor dietary and long-term medical interventions. Visit website.

    Heteron Biotechnologies

    Presenter

    arrow
    Anastasia Rigas

    CEO

    Heteron's solution is a hand-held breath analyzer will screen and monitor for biomarkers of gastrointestinal and liver diseases. The technology is intended to replace existing diagnostic testing tools for point-of-care testing, ultimately allowing users to screen themselves and to monitor dietary and long-term medical interventions. Visit website.

    LEM Surgical

    Presenter

    arrow
    Yossi Bar

    CEO

    LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

    LEM Surgical

    Presenter

    arrow
    Yossi Bar

    CEO

    LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

    Satisfai Health

    Presenter

    arrow
    Solveig Johannessen

    CEO

    Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

    Satisfai Health

    Presenter

    arrow
    Solveig Johannessen

    CEO

    Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

    Efemoral Medical

    Presenter

    arrow
    Christopher Haig

    Co-Founder/Chief Executive Officer

    Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. The scaffold is strong enough to hold the vessel open, is flexible enough to accommodate the complex skeletal motion of the leg, and elutes a drug to prevent scarring inside the vessel which leads to the need for repeat procedures. The scaffold is naturally absorbed by the body over time, thus leaving behind no permanent implant. Visit website.

    Efemoral Medical

    Presenter

    arrow
    Christopher Haig

    Co-Founder/Chief Executive Officer

    Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. The scaffold is strong enough to hold the vessel open, is flexible enough to accommodate the complex skeletal motion of the leg, and elutes a drug to prevent scarring inside the vessel which leads to the need for repeat procedures. The scaffold is naturally absorbed by the body over time, thus leaving behind no permanent implant. Visit website.

  • Tensor Surgical

    Presenter

    arrow
    Justin Anderson

    CEO

    Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures.  Visit website.

    Tensor Surgical

    Presenter

    arrow
    Justin Anderson

    CEO

    Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures.  Visit website.

    Hy2Care

    Presenter

    arrow
    Leo Smit

    CEO

    Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

    Hy2Care

    Presenter

    arrow
    Leo Smit

    CEO

    Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

    KelaHealth

    Presenter

    arrow
    Bora Chang

    Founder & CEO

    The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website.

    KelaHealth

    Presenter

    arrow
    Bora Chang

    Founder & CEO

    The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website.

    Nousq

    Presenter

    arrow
    Dr Lynne Lim

    Founder & CEO

    NousQ is a Singapore medical device start up with the world’s first robotic handheld surgical applicator aiming to insert ear tubes with just one click, in one second. By moving surgery from the operating theatre/ general anesthesia setting to the clinic/ local anesthesia setting, over 100 million more patients with middle ear infection can be helped.  Visit website.

    Nousq

    Presenter

    arrow
    Dr Lynne Lim

    Founder & CEO

    NousQ is a Singapore medical device start up with the world’s first robotic handheld surgical applicator aiming to insert ear tubes with just one click, in one second. By moving surgery from the operating theatre/ general anesthesia setting to the clinic/ local anesthesia setting, over 100 million more patients with middle ear infection can be helped.  Visit website.

    NEVENT

    Presenter

    arrow
    Rhodel Dacanay

    Anesthesiologist/Inventor

    The NEVENT Safety Sheath is a newly patented medical device that provides the only effective method of preventing the patient harm and medical system costs of retained guidewires after vascular catheter placement. Engineering out human error and providing safer care to our patients.

    NEVENT

    Presenter

    arrow
    Rhodel Dacanay

    Anesthesiologist/Inventor

    The NEVENT Safety Sheath is a newly patented medical device that provides the only effective method of preventing the patient harm and medical system costs of retained guidewires after vascular catheter placement. Engineering out human error and providing safer care to our patients.

    InkSpace Imaging

    Presenter Innovator

    arrow
    Peter Fischer

    CEO

    InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.

    InkSpace Imaging

    Presenter Innovator

    arrow
    Peter Fischer

    CEO

    InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.

    ZuriMED Technologies

    Presenter

    arrow
    Xiang Li

    CEO, Co-founder

    The Surgical-Fiberlcok technology functions like a surgical “sewing” machine, mechanically “interlocking” the medical patch fibers into soft tissue, allowing the surgeon to attach patches in an easier, faster, and more reliable way for various clinical applications for soft-tissue repair and augmentation. The enabling device for this technology, called FiberLocker® System, received FDA clearance for rotator cuff reinforcement in December 2024. Visit website.

    ZuriMED Technologies

    Presenter

    arrow
    Xiang Li

    CEO, Co-founder

    The Surgical-Fiberlcok technology functions like a surgical “sewing” machine, mechanically “interlocking” the medical patch fibers into soft tissue, allowing the surgeon to attach patches in an easier, faster, and more reliable way for various clinical applications for soft-tissue repair and augmentation. The enabling device for this technology, called FiberLocker® System, received FDA clearance for rotator cuff reinforcement in December 2024. Visit website.

    Vantis Vascular

    Presenter

    arrow
    Jason Turner

    CEO

    Description coming soon. Visit website.

    Vantis Vascular

    Presenter

    arrow
    Jason Turner

    CEO

    Description coming soon. Visit website.

    LearuUp Systems

    Presenter

    arrow
    Carlos Granada

    Co-Founder

    LearUp is looking to accelerate clinical trial timelines. The only All-in-one Solution. Smart patient matching and data-driven platform that reduces clinical trial timelines without risking quality. Visit website.

    LearuUp Systems

    Presenter

    arrow
    Carlos Granada

    Co-Founder

    LearUp is looking to accelerate clinical trial timelines. The only All-in-one Solution. Smart patient matching and data-driven platform that reduces clinical trial timelines without risking quality. Visit website.

  • Scout Health

    Presenter

    arrow
    Alex Jiao

    CEO

    Scout Health is bringing rapid molecular testing to the point-of-care. The Scout System packages similar technology to PCR lab-grade tests that normally require a clinic to be performed into a small hub and single-use tests. The system is currently approved for the testing of COVID, with additional tests for common illnesses in development.  Visit website.

    Scout Health

    Presenter

    arrow
    Alex Jiao

    CEO

    Scout Health is bringing rapid molecular testing to the point-of-care. The Scout System packages similar technology to PCR lab-grade tests that normally require a clinic to be performed into a small hub and single-use tests. The system is currently approved for the testing of COVID, with additional tests for common illnesses in development.  Visit website.

  • Bionic Vision Technologies

    Presenter

    arrow
    Ash Attia

    CEO

    BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

    Bionic Vision Technologies

    Presenter

    arrow
    Ash Attia

    CEO

    BVT Bionic Eye System is a suprachoroidal visual implant that has been designed to restore functional vision to the blind suffering from inherited retinal diseases. The Bionic Eye System consists of a retinal implant that receives visual images that are captured, processed, and transferred via a wearable device and processing unit.  Visit website.

  • Solenic Medical

    Presenter

    arrow
    James Lancaster

    CEO

    Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

    Solenic Medical

    Presenter

    arrow
    James Lancaster

    CEO

    Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

  • Biorithm

    Presenter

    arrow
    Amrish Nair

    Founder/Director

    Femom is a comprehensive maternity care platform to improve perinatal outcomes through mobile technology and data science. Designed for in-home and hospital use, Femom's priority solution enables healthcare professionals to gain new insights to the health of the mother and fetus while offering more convenience and information. Visit website.

    Biorithm

    Presenter

    arrow
    Amrish Nair

    Founder/Director

    Femom is a comprehensive maternity care platform to improve perinatal outcomes through mobile technology and data science. Designed for in-home and hospital use, Femom's priority solution enables healthcare professionals to gain new insights to the health of the mother and fetus while offering more convenience and information. Visit website.

  • Aqua Medical

    Presenter

    arrow
    Lloyd Mencinger

    President & CEO

    Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy. Visit website.

    Aqua Medical

    Presenter

    arrow
    Lloyd Mencinger

    President & CEO

    Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy. Visit website.

  • Atmo Biosciences

    Presenter

    arrow
    Malcolm Hebblewhite

    President

    The Atmo Gas Capsule is a unique ingestible capsule to provides unique insights into gut health and microbiome function. The device assesses the functional health of the GI system by means of measuring gaseous biomarkers as it passes through the GI system. Atmo Biosciences investigational device offers the potential to shed new light on disorders of the gut, beginning with highly prevalent motility disorders such as gastroparesis and slow transit constipation. Visit website.

    Atmo Biosciences

    Presenter

    arrow
    Malcolm Hebblewhite

    President

    The Atmo Gas Capsule is a unique ingestible capsule to provides unique insights into gut health and microbiome function. The device assesses the functional health of the GI system by means of measuring gaseous biomarkers as it passes through the GI system. Atmo Biosciences investigational device offers the potential to shed new light on disorders of the gut, beginning with highly prevalent motility disorders such as gastroparesis and slow transit constipation. Visit website.

  • Wellumio

    Presenter

    arrow
    Dr Shieak Tzeng

    Co-founder & CEO

    Wellumio is a venture-backed company specializing in portable MRI solutions for acute neuroimaging applications. The company’s core enabling technology is a novel pulse-gradient free nuclear magnetic resonance sensor platform with an initial focus on acute stroke triage and diagnosis. Visit website.

    Wellumio

    Presenter

    arrow
    Dr Shieak Tzeng

    Co-founder & CEO

    Wellumio is a venture-backed company specializing in portable MRI solutions for acute neuroimaging applications. The company’s core enabling technology is a novel pulse-gradient free nuclear magnetic resonance sensor platform with an initial focus on acute stroke triage and diagnosis. Visit website.

  • BrainSpace

    Presenter

    arrow
    Caitlin Morse

    CEO

    BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

    BrainSpace

    Presenter

    arrow
    Caitlin Morse

    CEO

    BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

  • Heteron Biotechnologies

    Presenter

    arrow
    Anastasia Rigas

    CEO

    Heteron's solution is a hand-held breath analyzer will screen and monitor for biomarkers of gastrointestinal and liver diseases. The technology is intended to replace existing diagnostic testing tools for point-of-care testing, ultimately allowing users to screen themselves and to monitor dietary and long-term medical interventions. Visit website.

    Heteron Biotechnologies

    Presenter

    arrow
    Anastasia Rigas

    CEO

    Heteron's solution is a hand-held breath analyzer will screen and monitor for biomarkers of gastrointestinal and liver diseases. The technology is intended to replace existing diagnostic testing tools for point-of-care testing, ultimately allowing users to screen themselves and to monitor dietary and long-term medical interventions. Visit website.

  • LEM Surgical

    Presenter

    arrow
    Yossi Bar

    CEO

    LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

    LEM Surgical

    Presenter

    arrow
    Yossi Bar

    CEO

    LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

  • Satisfai Health

    Presenter

    arrow
    Solveig Johannessen

    CEO

    Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

    Satisfai Health

    Presenter

    arrow
    Solveig Johannessen

    CEO

    Satisfai Health is a software company focusing on computer vision AI for gastroenterology, across both endoscopic and ultrasound imaging. Our products are used by pharmaceutical companies and healthcare providers to digitally assess important, life-altering conditions, including Inflammatory Bowel Disease and pre-Esophageal Cancer. Visit website.

  • Efemoral Medical

    Presenter

    arrow
    Christopher Haig

    Co-Founder/Chief Executive Officer

    Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. The scaffold is strong enough to hold the vessel open, is flexible enough to accommodate the complex skeletal motion of the leg, and elutes a drug to prevent scarring inside the vessel which leads to the need for repeat procedures. The scaffold is naturally absorbed by the body over time, thus leaving behind no permanent implant. Visit website.

    Efemoral Medical

    Presenter

    arrow
    Christopher Haig

    Co-Founder/Chief Executive Officer

    Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. The scaffold is strong enough to hold the vessel open, is flexible enough to accommodate the complex skeletal motion of the leg, and elutes a drug to prevent scarring inside the vessel which leads to the need for repeat procedures. The scaffold is naturally absorbed by the body over time, thus leaving behind no permanent implant. Visit website.

  • Tensor Surgical

    Presenter

    arrow
    Justin Anderson

    CEO

    Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures.  Visit website.

    Tensor Surgical

    Presenter

    arrow
    Justin Anderson

    CEO

    Tensor Surgical develops technologies for orthopedic soft tissue repair sports medicine. The company’s portfolio of products consists of solutions to simplify and reduce the cost rotator cuff repair and bicep tenodesis procedures.  Visit website.

  • Hy2Care

    Presenter

    arrow
    Leo Smit

    CEO

    Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

    Hy2Care

    Presenter

    arrow
    Leo Smit

    CEO

    Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

  • KelaHealth

    Presenter

    arrow
    Bora Chang

    Founder & CEO

    The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website.

    KelaHealth

    Presenter

    arrow
    Bora Chang

    Founder & CEO

    The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website.

  • Nousq

    Presenter

    arrow
    Dr Lynne Lim

    Founder & CEO

    NousQ is a Singapore medical device start up with the world’s first robotic handheld surgical applicator aiming to insert ear tubes with just one click, in one second. By moving surgery from the operating theatre/ general anesthesia setting to the clinic/ local anesthesia setting, over 100 million more patients with middle ear infection can be helped.  Visit website.

    Nousq

    Presenter

    arrow
    Dr Lynne Lim

    Founder & CEO

    NousQ is a Singapore medical device start up with the world’s first robotic handheld surgical applicator aiming to insert ear tubes with just one click, in one second. By moving surgery from the operating theatre/ general anesthesia setting to the clinic/ local anesthesia setting, over 100 million more patients with middle ear infection can be helped.  Visit website.

  • NEVENT

    Presenter

    arrow
    Rhodel Dacanay

    Anesthesiologist/Inventor

    The NEVENT Safety Sheath is a newly patented medical device that provides the only effective method of preventing the patient harm and medical system costs of retained guidewires after vascular catheter placement. Engineering out human error and providing safer care to our patients.

    NEVENT

    Presenter

    arrow
    Rhodel Dacanay

    Anesthesiologist/Inventor

    The NEVENT Safety Sheath is a newly patented medical device that provides the only effective method of preventing the patient harm and medical system costs of retained guidewires after vascular catheter placement. Engineering out human error and providing safer care to our patients.

  • InkSpace Imaging

    Presenter Innovator

    arrow
    Peter Fischer

    CEO

    InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.

    InkSpace Imaging

    Presenter Innovator

    arrow
    Peter Fischer

    CEO

    InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.

  • ZuriMED Technologies

    Presenter

    arrow
    Xiang Li

    CEO, Co-founder

    The Surgical-Fiberlcok technology functions like a surgical “sewing” machine, mechanically “interlocking” the medical patch fibers into soft tissue, allowing the surgeon to attach patches in an easier, faster, and more reliable way for various clinical applications for soft-tissue repair and augmentation. The enabling device for this technology, called FiberLocker® System, received FDA clearance for rotator cuff reinforcement in December 2024. Visit website.

    ZuriMED Technologies

    Presenter

    arrow
    Xiang Li

    CEO, Co-founder

    The Surgical-Fiberlcok technology functions like a surgical “sewing” machine, mechanically “interlocking” the medical patch fibers into soft tissue, allowing the surgeon to attach patches in an easier, faster, and more reliable way for various clinical applications for soft-tissue repair and augmentation. The enabling device for this technology, called FiberLocker® System, received FDA clearance for rotator cuff reinforcement in December 2024. Visit website.

  • Vantis Vascular

    Presenter

    arrow
    Jason Turner

    CEO

    Description coming soon. Visit website.

    Vantis Vascular

    Presenter

    arrow
    Jason Turner

    CEO

    Description coming soon. Visit website.

  • LearuUp Systems

    Presenter

    arrow
    Carlos Granada

    Co-Founder

    LearUp is looking to accelerate clinical trial timelines. The only All-in-one Solution. Smart patient matching and data-driven platform that reduces clinical trial timelines without risking quality. Visit website.

    LearuUp Systems

    Presenter

    arrow
    Carlos Granada

    Co-Founder

    LearUp is looking to accelerate clinical trial timelines. The only All-in-one Solution. Smart patient matching and data-driven platform that reduces clinical trial timelines without risking quality. Visit website.

star Special LSI Rates Available
The Ritz-Carlton 1
The Ritz-Carlton 2
The Ritz-Carlton 3
The Ritz-Carlton 4
event venue

The Ritz-Carlton® Millenia Singapore

Located in the heart of Marina Bay, The Ritz-Carlton, Millenia Singapore is renowned for panoramic views from its spacious guestrooms and suites together with award-winning hospitality synonymous with The Ritz-Carlton brand.

The Ritz-Carlton 1
The Ritz-Carlton 2
The Ritz-Carlton 3
The Ritz-Carlton 4
Book With Special LSI Rate
More resources

Resources from the LSI Alumni

Our resource library contains thousands of insightful executive sessions from previous events, captivating photos, and the latest alumni news. Dive in today to prepare for your next LSI experience.

resource 1 resource 3
resource 2 resource 4

Stay tuned, more
info coming soon